Articles related to PULMONARY EMBOLISM

Blood clots manifest differently in each patient, with symptoms ranging from severe back pain to unexplained bloating, challenging standard diagnostic approaches.

AI’s pivotal role in pulmonary embolism diagnosis transforms patient care by achieving remarkable diagnostic efficiency and accuracy, ensuring timely and targeted interventions for those in critical need.

This study underscores the importance of refining and adhering to outpatient management protocols for low-risk acute pulmonary embolism patients. Despite the proven safety and effectiveness of such approaches, only one third of eligible patients were discharged for outpatient care between 2012 and 2020, indicating a significant gap in practice.

Explore how Artificial Intelligence is transforming the management of acute pulmonary embolism, from enhancing diagnostic accuracy to optimizing treatment strategies. Learn more about the synergy between AI and PERT teams, and how this collaboration promises advancements in personalized care and improved patient outcomes.

Risks for ischemic stroke, hemorrhagic stroke, MI, and pulmonary embolism were all lower for older patients receiving a bivalent vaccine booster versus the monovalent vaccine. The results “provide reassurance regarding the continued use of this bivalent vaccine.”

To assess short-term risk for severe cardiovascular events (excluding myocarditis and pericarditis) after COVID-19 vaccination, adults younger than 75 years hospitalized for PE, acute MI, hemorrhagic stroke, or ischemic stroke (73,325 events) were reviewed in relation to a 1st or 2nd COVID vaccine dose. No association was found between the Pfizer–BioNTech or Moderna vaccine and severe cardiovascular events. The first dose of the Oxford–AstraZeneca vaccine was associated with acute MI and PE in the second week after vaccination. An association with MI in the second week after a single dose of the Janssen vaccine could not be ruled out.